Synthetic antitumor agent derived from Et 743 shows promise following preliminary testing April 27, 1999 No Comments
DuPont presents somatostatin analogues YH-137 and YH-138 with antiangiogenic effects April 23, 1999 No Comments
Hybridon describes mixed-backbone anti-MDM2 antisense oligonucleotide active in vivo April 23, 1999 No Comments
Extensive preclinical evaluation establishes potential of novel antitumor agent --CHS-828 April 22, 1999 No Comments
Promising phase I/II data for 81C6 pave the way for phase III trials in brain tumor patients April 22, 1999 No Comments
PNU-159548 undergoes phase I trials; preclinical results presented at AACR meeting April 22, 1999 No Comments
RSS